Edwards Lifesciences (EW) Net Income towards Common Stockholders Growth (5y) (2014 - 2025)
Edwards Lifesciences (EW) Net Income towards Common Stockholders Growth (5y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.60% |
| Sep 30, 2025 | -14.94% |
| Jun 30, 2025 | 48.54% |
| Mar 31, 2025 | -15.13% |
| Dec 31, 2024 | -32.49% |
| Sep 30, 2024 | 58.03% |
| Jun 30, 2024 | -66.65% |
| Mar 31, 2024 | -36.34% |
| Dec 31, 2023 | 39.21% |
| Sep 30, 2023 | -26.40% |
| Jun 30, 2023 | -28.16% |
| Mar 31, 2023 | 10.51% |
| Dec 31, 2022 | 170.30% |
| Sep 30, 2022 | 15.09% |
| Jun 30, 2022 | 16.91% |
| Mar 31, 2022 | 10.17% |
| Dec 31, 2021 | 16.17% |
| Sep 30, 2021 | 19.19% |
| Jun 30, 2021 | 31.06% |
| Mar 31, 2021 | 18.79% |